Bluejay Diagnostics Cash Flow Statement (2022-2023) | BJDX

Cash Flow Statement Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023
Operating Activities
Net Income -2.07M-1.99M-2.81M-2.45M-2.68M-2.90M
Depreciation and Depletion 0.04M0.04M0.04M0.03M0.12M0.25M0.25M0.02M
Share-based Compensation 0.13M0.11M0.11M0.09M0.22M0.03M-0.04M-0.02M
Gains from Sales and Divestitures 0.37M0.02M0.02M
Gains from Investment Securities -788.000.01M-0.00M0.00M0.06M0.04M0.03M-1.00
Asset Writedowns and Impairment 0.03M
Non-cash Items 0.02M0.56M0.03M0.03M
Cash from Operations -1.88M-1.66M-1.26M-2.94M-2.93M-1.48M-1.13M-2.78M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles 0.03M0.04M0.04M0.04M0.04M0.04M0.02M0.03M
Depreciation & Amortization (CF) 0.04M0.04M0.04M0.03M0.04M0.20M0.25M0.02M
Change in Working Capital
Change in Inventory 0.89M-0.22M
Change in Account Payables 0.42M-0.52M0.02M0.38M-0.31M-0.11M0.45M-0.25M
Change in Accured Expenses 0.11M0.14M0.21M-0.11M-0.01M0.49M0.46M-0.97M
Other Working Capital Changes -0.31M-0.27M-0.39M1.01M0.45M-0.64M-0.03M-0.70M
Investing Activities
Capital Expenditures 0.05M0.12M0.79M0.24M0.34M0.20M0.07M0.09M
Cash from Investing Activities -0.05M-0.12M-0.79M-0.24M-0.34M-0.20M-0.07M-0.09M
Financing Activities
Other financing activities 0.13M0.11M0.00M0.03M0.41M
Cash from Financing Activities -0.06M-0.00M1.18M-0.00M
Additional items
Change in Cash -1.92M-1.78M-2.05M-3.17M-3.33M-1.68M-0.02M-2.87M
Free Cash Flow -1.92M-1.78M-2.05M-3.18M-3.27M-1.68M-1.20M-2.87M
Net Cash Flow -1.92M-1.78M-2.05M-3.18M-3.33M-1.68M-0.02M-2.87M